chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to unknown number of patients of unknown age and gender. The patient's current conditions and medical history were not reported. Since unspecified dates in October 2014, the patients were vaccinated with doses of improperly stored PROQUAD (Merck) injection (unknown strength and route). Concomitant medications were not reported. No adverse effect was reported. The outcome of the events was unknown. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Injection site red, painful, warm to touch, itchy swollen, 9 cm x 7 cm of redness.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a unknown number of patients of unknown age and gender. The patient's current conditions and medical history were not reported. Since unspecified dates in October 2014, the patients were vaccinated with doses of improperly stored RECOMBIVAX HB (unknown strength and route) (incorrect product storage). Concomitant medications were not reported. No adverse effect was reported. The outcome of the events were unknown. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: DTAPHEPBIP, HIBV, MMRV
Symptoms: Injection site pruritus, Vaccination site erythema, Vaccination site warmth
Clinical narrative: 2.5 in x 2 in erythematous circle surrounding vaccine site. Not painful to touch, mild warmth, itchy.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to unknown number of patients of unknown age and gender. This patient's current conditions and medical history were not reported. Since unspecified dates in October 2014, the patients were vaccinated with doses of improperly stored ROTATEQ (unknown strength and route defaulted to oral) (incorrect product storage). Concomitant medications were not reported. No adverse effect was reported. The outcome of the events was unknown. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 76.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: Vaccine administered 3/4/15. Later on arm got red, swelled and ached. This continued for a few weeks. Pt iced arm and took it easy. Pt. came in and had noticeable swelling above 3 weeks later. Continued to ice. On May 20th pt still has some swelling.
Age: 76.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Vaccine administered 3/4/15. Later on arm got red, swelled and ached. This continued for a few weeks. Pt iced arm and took it easy. Pt. came in and had noticeable swelling above 3 weeks later. Continued to ice. On May 20th pt still has some swelling.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Erythema, Induration, Swelling
Clinical narrative: Pt developed a bump the size of a quarter, firm, red, slightly raised.
Sex: F
Vaccine: HPV4
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: This spontaneous report was received from a consumer and refers to "beyond 26 years of age" female patient. The patient's medical history, concurrent conditions and concomitant medications were not reported. The reporter stated that on an unknown date the patient (her girlfriend) who was beyond 26 years of age was vaccinated with GARDASIL (route of administration, lot number were not reported). There were no adverse effects reported. The reporter stated that she was beyond 26 years of age and she was also interested in receiving GARDASIL and wanted to localize the healthcare providers who could administer this product. Additional information is not expected because the reporter did not provide the contact details.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a Registered Nurse refers to an unspecified number of patients of unknown age and gender. On an unspecified day, the patients were vaccinated with improperly stored PROQUAD (Merck) lot # L002419 with the expiration date of 23-JUL-2016 (dose, unit and route were unspecified). No adverse effects reported. No product quality complaint involved. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Injection site induration, Injection site swelling
Clinical narrative: Pt received KINRIX Tuesday 5/19 and mom called to report large hard/swollen area by site of injection.
Sex: F
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: This spontaneous report was received from a physician and refers to an unspecified number of female patients of unknown age. No medical history, current conditions and concomitant therapies were reported. On an unknown date, the patients were vaccinated with M-M-R II. Lot #, expiration date, dose and route of administration were not reported. On an unknown date, the patients were tested for rubella immunity as a routine part of pre-pregnancy testing and their titers came back showing that they had no immunity to rubella. On an unknown date, the patients were revaccinated with unspecified rubella vaccine. The patients outcome was not reported. The relatedness between the event and M-M-R II was not reported. Additional information is not expected because the physician retired from her practice and had no longer records for these patients therefore she had no specified details regarding the patients involved.
Age: 2.0
Sex: U
Vaccine: HPV4
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a physician referring to a 2 year old patient of unknown gender. Information about pertinent medical history and drug reaction was not reported. On 12-MAY-2015, due to nursing error, the patient who was intended to receive VAQTA (dose, strength, frequency, route, lot# and expiration date were not reported) was vaccinated with a dose of GARDASIL (0.5 ml, strength, frequency, lot# and expiration date were not reported) intramuscularly. It was confirmed that the vaccine was not GARDASIL 9. No adverse effects were reported. Additional information is not expected since physician asked not to contacted.
Age: 5.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Injection site cellulitis, Injection site pain, Injection site vesicles
Clinical narrative: Left arm cellulitis with onset of vesicles below injection site. C/O Lt arm pain. Bactroban oint. to apply to lesions, cefdinir 250 mg/5 ml for 10 days.
Sex: U
Vaccine: HEP
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report was received from a pharmacist refers to a patient of unknown age. On 03-SEP-2014, the patient received the first dose of RECOMBIVAX HB, intramuscularly, 10 mg/ml (lot # was not reported) and was in pharmacy to receive the second dose of RECOMBIVAX HB  on 07-MAY-2015. No adverse effect was reported. The outcome of the events were unknown. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a clinical medical assistant refers to an unspecified patients of unknown age and gender. THere was no medical history, drug reaction/allergies and concomitant medication provided. On 20-MAY-2015, the unspecified patients were vaccinated with an improperly stored doses of ROTATEQ (route oral, dose, lot # and expiration date were not reported). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to unknown number of patients of unknown age and gender. The patient's current conditions and medical history were not reported. Since unspecified dates in October 2014, the patients were vaccinated with doses of improperly stored VAQTA (unknown strength and route) (incorrect product storage). Concomitant medications were not reported. No adverse effect was reported. The outcome of the events was unknown. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Injection site erythema, Injection site reaction, Injection site warmth, Skin tightness
Clinical narrative: Dad called to report area around injection site is red, hot and feels right, about 3 inches in diameter.
Age: 76.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Induration, Pain in extremity, Skin warm, Swelling
Clinical narrative: Large red swelling, hard spot, sore, feverish at spot, pain up and down arm to fingers.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Headache, Pruritus, Urticaria
Clinical narrative: Patient got the flu shot in the morning and went home. She called the pharmacy in the afternoon (about couple of hours later) and reported HIVES on back, arm, and scalp. She also added later itch and light headache. Symptoms were relieved by OTC BENADRYL.
Age: 61.0
Sex: F
Vaccine: TDAP, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Pt received ZOSTAVAX in upper (R) arm at 10:19am. PT tolerated well. Pt called 5/15 to report having "2 x 3" localized reddened area at vaccine site. It was slightly raised, itchy, and warm to touch. Denies any discharge or pain "It just feels a little sensitive." Taking ADVIL per dr. spoke with pt today (5-19-15) and she's doing much better. Swelling resolved.
Age: 65.0
Sex: F
Vaccine: PNC13, TDAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Swelling, redness and warmth to injection site/LD. Instructed pt to apply cold pack, OTC med for pain.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site erythema, Injection site vesicles
Clinical narrative: Large blister and erythema between 2 injection sites.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Cellulitis, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Injection site reaction- Pt had redness, swelling and pain beginning approximately 48 hrs after administration; swelling was larger than golf ball and spread down back of arm. Pt was diagnosed w/ cellulitis and given Abx tx.
Age: 89.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Lethargy, Malaise
Clinical narrative: This is a spontaneous report from a contactable consumer (patient's daughter) via sales representative. A 89 years old female patient received PREVNAR 13 on unknown date, at single dose. The patient went to the dentist before having vaccination and had several teeth filled. Concomitant medications were not provided. On unknown date (on the night of vaccination) the patient experienced high fever. The next day she got really sick with high fever and extreme lethargy. The site of her injection was very red, swollen and hot. She went to the Emergency room and was admitted spending 3 days in the hospital spiking fevers on and off the entire three days. At discharge doctors and nurse agreed that her illness was due to the vaccine. After continuing with fever on and off for several days she went back to her regular doctor and he too agreed that her illness was due to the vaccine. Final events outcome was unknown at time of report. The reporter considered that the patient illness could possibly be due to her dental procedures.
Age: 89.0
Sex: F
Vaccine: PNC13
Symptoms: Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer (patient's daughter) via sales representative. A 89 years old female patient received PREVNAR 13 on unknown date, at single dose. The patient went to the dentist before having vaccination and had several teeth filled. Concomitant medications were not provided. On unknown date (on the night of vaccination) the patient experienced high fever. The next day she got really sick with high fever and extreme lethargy. The site of her injection was very red, swollen and hot. She went to the Emergency room and was admitted spending 3 days in the hospital spiking fevers on and off the entire three days. At discharge doctors and nurse agreed that her illness was due to the vaccine. After continuing with fever on and off for several days she went back to her regular doctor and he too agreed that her illness was due to the vaccine. Final events outcome was unknown at time of report. The reporter considered that the patient illness could possibly be due to her dental procedures.
Age: 2.0
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Acute kidney injury, Dyspnoea, Haemoglobin decreased, Pneumonia pneumococcal, Streptococcus test positive
Clinical narrative: This is a spontaneous report from a contactable physician via a Pfizer sales representative. A 2-year-old female patient received 4 doses of PREVNAR 13, via an unspecified route of administration in right thigh, at single dose: first dose (Lot# F18963, Exp. date 28Feb2013, NDC 00005197101) on 05Mar2012, second dose (Lot# F29393, Exp. date 31Mar2012, NDC 00005197101) on 03May2012, third dose (Lot# F63666, Exp. date Jul2013, NDC 00005197101) on 05Jul2012 and fourth dose (Lot# G39292, Exp. date 31Jan2015, NDC 00005197101) on 25Nov2013. Relevant medical history included that the patient had preterm weight (premature birth) of 2000-2500 grams. Concomitant medications included DTAP vaccine, via an unspecified route of administration, on 25Nov2013, at unspecified dose, and HIB vaccine, via an unspecified route of administration, on 25Nov2013, at unspecified dose. Past drug history included ROTATEQ (at 2, 4 and 6 months), penicillin; MMR and varicella zoster vaccine. In Nov2014 the patient experienced Serotype 3 pneumonia with outcome of recovered. She was hospitalized in response to the event on 25Nov2014. Therapeutic measures were taken as a result of pneumonia and included treatment with intravenous ROCEPHIN. Blood culture performed in the hospital (Nov2014) was positive for pneumonia serotype 3. She also went into acute renal failure in Nov2014, from which recovered on an unspecified date. The reporter was unsure if she had dialysis for renal failure. Always in Nov2014 hemoglobin dropped from 10 to 2.9 in 6 hours. Symptom of dropped hemoglobin was that she started having more breathing problems. The event recovered on an unspecified date. Physician stated he believes this was a vaccine failure. There was no reason for which the patient should develop these events.
Age: 2.0
Sex: F
Vaccine: DTAP, HIBV, PNC13
Symptoms: Vaccination failure
Clinical narrative: This is a spontaneous report from a contactable physician via a Pfizer sales representative. A 2-year-old female patient received 4 doses of PREVNAR 13, via an unspecified route of administration in right thigh, at single dose: first dose (Lot# F18963, Exp. date 28Feb2013, NDC 00005197101) on 05Mar2012, second dose (Lot# F29393, Exp. date 31Mar2012, NDC 00005197101) on 03May2012, third dose (Lot# F63666, Exp. date Jul2013, NDC 00005197101) on 05Jul2012 and fourth dose (Lot# G39292, Exp. date 31Jan2015, NDC 00005197101) on 25Nov2013. Relevant medical history included that the patient had preterm weight (premature birth) of 2000-2500 grams. Concomitant medications included DTAP vaccine, via an unspecified route of administration, on 25Nov2013, at unspecified dose, and HIB vaccine, via an unspecified route of administration, on 25Nov2013, at unspecified dose. Past drug history included ROTATEQ (at 2, 4 and 6 months), penicillin; MMR and varicella zoster vaccine. In Nov2014 the patient experienced Serotype 3 pneumonia with outcome of recovered. She was hospitalized in response to the event on 25Nov2014. Therapeutic measures were taken as a result of pneumonia and included treatment with intravenous ROCEPHIN. Blood culture performed in the hospital (Nov2014) was positive for pneumonia serotype 3. She also went into acute renal failure in Nov2014, from which recovered on an unspecified date. The reporter was unsure if she had dialysis for renal failure. Always in Nov2014 hemoglobin dropped from 10 to 2.9 in 6 hours. Symptom of dropped hemoglobin was that she started having more breathing problems. The event recovered on an unspecified date. Physician stated he believes this was a vaccine failure. There was no reason for which the patient should develop these events.
Age: 0.18
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a 9 weeks old patient. On 14-MAY-2015 the patient was vaccinated once with first dose oral, ROTATEQ (lot # K00791 with expiration date: 29-MAR-2016; dose: 2 ml, orally) which was incorrectly stored. No adverse effects were reported. {Additional information has been requested./Additional information is not expected.}
Age: 14.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 14 year old patient of an unknown gender. On 10-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 15.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 15 year old patient of an unknown gender. On 16-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 14.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 14 year old patient of an unknown gender. On 17-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 14.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 14 year old patient of unknown gender. On 21-JAN-2015, the patient was vaccinated with improperly stored GARDASIL (lot # H012643 and expiry date: 30-MAR-2015). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 14.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 14 year old patient of an unknown gender. On 02-MAR-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 13.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 13 year old patient of unknown gender. On 23-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 13.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 13 year old patient of unknown gender. On 03-MAR-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 78.0
Sex: M
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: On 5/19/15 patient presented to clinic/office, for evaluation of concerns regarding left deltoid erythema and itching with onset of symptoms presenting seven days post-administration of PREVNAR 14 vaccine. No immediate concerns post-administration were noted. Patient manifested no symptoms of respiratory distress, or systemic reactive response. Advised to apply cool compress and may use OTC allergy-relief medications such as CLARITIN.
Age: 12.0
Sex: U
Vaccine: HPV4, HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 12 year old patient of unknown gender. On 02-MAR-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 13.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 13 (reported as 14) year old patient of an unknown gender. On 15-JAN-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 0.17
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 6   week old patient of  an unknown gender. On 19-JAN-2015, the patient was vaccinated with improperly stored ROTATEQ (either lot # K007247 and expiry date: 17-MAR-2016 or lot # K006805 and expiry date: 24-MAR-2016. No adverse events were reported. No product quality complaint PQC was reported for ROTATEQ. This is one of several repots from the same reporter. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling, Local reaction
Clinical narrative: Localized reaction to varicella vaccination on Rt thigh SQ. Given KEFLEX and prednisolone. Silver dollar sized raised area with surrounding erythema.
Age: 81.0
Sex: M
Vaccine: PNC13, VARZOS
Symptoms: Rash vesicular
Clinical narrative: Varicella type rash of upper left back and chest.
Age: 0.23
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 11 week old patient of unknown gender. On 22-JAN-2015, the patient was vaccinated with improperly stored ROTATEQ (lot # K007247 and expiry date: 17-MAR-2016 or lot # K006805 and expiry date: 24-MAR-2016. No adverse events were reported. No product quality complaint (PQC) was reported for ROTATEQ. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 1.05
Sex: M
Vaccine: HEPA, MMRV
Symptoms: Eyelid rash, Hyperaesthesia, Urticaria
Clinical narrative: Patient had a reaction on the way to the check out counter. Patient started to develop a rash around his eyes, as well as skin sensitivity and hives. Dr. then assesed him and asked him to go back to the room and we grabbed vitals which all showed stability, and gave him 5mls of Benadryl orally. Patient then was monitored for an additional 15min and had no complications or difficulty breathing or abnormal vitals. Patients hive and rash around the eyes started to disappear. Patient was discharged with Benadryl perscription and educated on sign and symptoms to look out for.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Cellulitis
Clinical narrative: Cellulitis.
Age: 58.0
Sex: F
Vaccine: PPV, VARZOS
Symptoms: Injection site erythema, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: Round Red swollen rash around/near injection site- hot to touch and large bump.
Age: 0.21
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Body temperature increased, CSF glucose decreased, CSF protein increased, CSF red blood cell count, CSF white blood cell count negative
Clinical narrative: Was awake at 2200 in father's arms when father noted he was turning his head to the right and R arm and R leg became stiff, eyes rolled back. Entire episode lasted almost one minute. While on the phone with 911, episode stopped. Brought to ED, where temp was 38.5.
Age: 0.21
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Computerised tomogram head abnormal, Eye movement disorder, Musculoskeletal stiffness, Posture abnormal
Clinical narrative: Was awake at 2200 in father's arms when father noted he was turning his head to the right and R arm and R leg became stiff, eyes rolled back. Entire episode lasted almost one minute. While on the phone with 911, episode stopped. Brought to ED, where temp was 38.5.
Age: 27.0
Sex: F
Vaccine: HEP, HEPA, TDAP
Symptoms: Eye movement disorder, Presyncope, Tonic clonic movements
Clinical narrative: Pt had vasovagal reaction followed by transient tonic-clonic limb movements, eyes rolling back and lasted for 1.5 minutes.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site rash, Pain, Pruritus
Clinical narrative: A small cluster of round rashes the size of a quarter at the site of injection.  She compained of itchiness and pain that come and go. The symptoms has not been resolved ever since.  Advise patient to see her primary doctor.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Discomfort, Injection site pain, Injection site pruritus, Injection site rash
Clinical narrative: A small cluster of round rashes the size of a quarter at the site of injection.  She compained of itchiness and pain that come and go. The symptoms has not been resolved ever since.  Advise patient to see her primary doctor.
Age: 32.0
Sex: M
Vaccine: JEV1
Symptoms: Audiogram abnormal, Deafness unilateral
Clinical narrative: Member woke up in the morning and was unable to hear out of his right ear. No sinus congestion, rhinorrhea, sore throat. No evidence of infection of effusion. Put on Methylprednisolone 4 MG.
Age: 0.2
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Enema administration, Intussusception
Clinical narrative: Developed intussusception 6 days after administration of 2 month vaccines including Rotarix.  Required reduction with air enema.
Age: 38.0
Sex: F
Vaccine: FLUX
Symptoms: Activities of daily living impaired, Insomnia, Musculoskeletal pain
Clinical narrative: Extreme arm pain in the shoulder. Interferes with sleep, showering, cleaning etc. Pain since vaccination. Went to doctor and was prescribed Naproxen (2 refills). Suggested that I go to orthopedic surgeon or get X-ray but did not pursue do to finances.
Age: 59.0
Sex: M
Vaccine: TDAP
Symptoms: Cough, Oropharyngeal pain, Pyrexia
Clinical narrative: Fever, sore throat, severe coughing after Tdap.
Age: 69.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Pain, Pruritus, Rash, Swelling
Clinical narrative: Redness, Swelling, Rash Soreness and itching.
Age: 72.0
Sex: M
Vaccine: PPV
Symptoms: Erythema, Swelling
Clinical narrative: Redness and swelling the size of a golf ball, it was not at the injection site by further down the arm.
Age: 68.0
Sex: F
Vaccine: PNC13
Symptoms: Anxiety, Chills, Dizziness, Local reaction, Nausea
Clinical narrative: Vaccine administered 2:50 PM; pt states left arm had increasing pain, late evening she felt "bad", body aches, chills, then nausea with dry heaves which left her feeling she might pass out. She called 911 - cleared by Medic eval. Taken to Urgent Care for eval. Urgent care eval: vasovagal attack/anxiety and local reaction. IV placed, 1 liter NS and 0.5mg Ativan given.
Age: 68.0
Sex: F
Vaccine: PNC13
Symptoms: Pain, Pain in extremity, Presyncope, Retching
Clinical narrative: Vaccine administered 2:50 PM; pt states left arm had increasing pain, late evening she felt "bad", body aches, chills, then nausea with dry heaves which left her feeling she might pass out. She called 911 - cleared by Medic eval. Taken to Urgent Care for eval. Urgent care eval: vasovagal attack/anxiety and local reaction. IV placed, 1 liter NS and 0.5mg Ativan given.
Age: 0.24
Sex: F
Vaccine: DTAPIPVHIB, RV5
Symptoms: Abdominal pain upper, Diarrhoea
Clinical narrative: Severe diarrhea for over four weeks 7-9 times per day, cries out in stomach pain. Started infant on probiotics once per day. No further doses of Rotateq.
Age: 6.0
Sex: M
Vaccine: DTAP, MMR, VARCEL
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Redness swelling warm to touch.
Age: 1.24
Sex: M
Vaccine: DTAPIPVHIB, PNC13
Symptoms: Excoriation, Injection site urticaria
Clinical narrative: Hives on L thigh, spread to R thigh, intermittent, comes and goes; rx Benadryl.
Age: 67.0
Sex: M
Vaccine: PNC13
Symptoms: Erythema, Rash macular, Rash papular, Rash pruritic, Skin plaque
Clinical narrative: Received PCV-13 on 5/19/15. On 5/20/15 started with itchy rash (L) lower abdomen. Seen on 5/27/15 for rash: large macular plaque (L) lower abdomen, red and warm to touch with surrounding area of pink with erythematous papules at midline-also, noted same rash at top of gluteal crease bilaterally.
Age: 67.0
Sex: M
Vaccine: PNC13
Symptoms: Skin warm
Clinical narrative: Received PCV-13 on 5/19/15. On 5/20/15 started with itchy rash (L) lower abdomen. Seen on 5/27/15 for rash: large macular plaque (L) lower abdomen, red and warm to touch with surrounding area of pink with erythematous papules at midline-also, noted same rash at top of gluteal crease bilaterally.
Age: 75.0
Sex: M
Vaccine: PNC13, TDAP
Symptoms: Inflammation, Rash
Clinical narrative: Localized inflamation and rash. Start CLARITIN next 1-2 weeks. Hydrocortisone crm BID.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEP, HEPA, MMRV
Symptoms: Blister, Pruritus
Clinical narrative: MMR/Varicella (PROQUAD) given on 5/15/15. By 5/17 pt had egg sized area with cluster of fluid filled blisters. Itchy. By 5/19 when reported by mom where already dried up. No other sx.
Sex: U
Vaccine: VARZOS
Symptoms: Extra dose administered, Renal transplant
Clinical narrative: Information has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent condition and medical history were not reported. On an unknown date in 2007, the patient was received with the first dose of ZOSTAVAX (strength, lot#, expiration date, dose and route were unknown), and the patient had a renal transplant in 2013, and the patient was received with the second dose of ZOSTAVAX (strength, lot#, expiration date, dose and route were unknown) on an unknown date in 2015. The outcome of renal transplant was unknown. Upon internal review, the event of renal transplant was considered to be medically significant. Additional information is not expected as there was no reporter's contact information.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Staring, Unresponsive to stimuli, Vomiting
Clinical narrative: Mother observed child looking to the left with eyes and head. Mom thought she was going to vomit. Child walked with assistance to the bathroom and vomited. Went back to bed and would not respond to verbal commands. Mom phoned 911, she was transported to local hospital with dx of possible seizure.
Age: 64.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site rash, Pruritus, Skin warm
Clinical narrative: Pt described rash to left arm-from elbow to shoulder. Describes as sunburn appearance, itchy, warm to touch. Rash not witnessed by clinic-reported by phone call only 5/26/15.
Age: 15.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 15 year old patient of an unknown gender. On 25-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a healthcare worker refers to a 4 year old patient of unknown gender. Concurrent condition, medical history and concomitant medications were not provided. On 12-MAR-2015, the patient was vaccinated with a dose of improperly stored PROQUAD (Merck) (lot # K010797, expiry 04-FEB-2016). No adverse experiences reported. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 0.28
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 3 month old patient of an unknown gender. On 16-JAN-2015, the patient was vaccinated with improperly stored ROTATEQ (lot # K007247 and expiry date: 17-MAR-2016 or lot# K006805 and expiry date: 24-MAR-2016). No adverse events were reported. No product quality complaint (PQC) was reported for ROTATEQ. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 0.19
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 10 week old patient of an unknown gender. On 09-FEB-2015, the patient was vaccinated with improperly stored ROTATEQ (lot # K007247 and expiry date 17-MAR-2016 or lot # K006805 and expiry date: 24-MAR-2016. No adverse events were reported. No product quality complaint PQC was reported for ROTATEQ. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 15.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 15 year old patient of an unknown gender. On 17-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 12.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 12 year old patient of an unknown gender. On 18-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 16.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 16 year old patient of an unknown gender. On 03-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 14.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 14 year old patient of an unknown gender. On 24-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K0077264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 15.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 15 year old patient of an unknown gender. On 30-JAN-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 15.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 15 year old patient of an unknown gender. On 19-JAN-2015, the patient was vaccinated with improperly stored GARDASIL (lot # H012643 and expiry date: 30-MAR-2015). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 12.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 12 year old patient of unknown gender. On 11-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 13.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 13 year old patient of unknown gender. On 16-JAN-2015, the patient was vaccinated with improperly stored GARDASIL (lot # H012643 and expiry date: 30-MAR-2015). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 14.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 14 year old patient of unknown gender. On 25-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 13.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 13 year old patient of unknown gender. On 26-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 14.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 14 year old patient of unknown gender. On 26-JAN-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 12.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 12 year old patient of unknown gender. On 26-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 11.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 11 year old patient of unknown gender. On 02-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 12.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 12 year old patient of unknown gender. On 15-JAN-2015, the patient was vaccinated with improperly stored GARDASIL (lot # H012643 and expiry date: 30-MAR-2015). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 11.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 11 year old patient of unknown gender. On 03-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 17.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 17 year old patient of an unknown gender. On 27-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 18.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 18 year old patient of an unknown gender. On 23-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 19.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 18 year old patient of an unknown gender. On 14-JAN-2015, the patient was vaccinated with improperly stored GARDASIL (lot # J013324 and expiry date: 12-FEB-2016). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 21.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 21 year old patient of an unknown gender. On 04-MAR-2015, the patient was vaccinated with improperly stored GARDASIL (lot # J013277 and expiry date: 06-AUG-201). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: FLU3
Symptoms: Hypersensitivity
Clinical narrative: This case was reported by a other health professional via call center representative and described the occurrence of allergic reaction in a unk patient who received Flu vaccine. On an unknown date, the patient received flu vaccine at an unknown dose. On an unknown date, unknown after receiving Flu vaccine, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction was unknown. It was unknown if the reporter considered the allergic reaction to be related to Flu vaccine. Additional information received: Patient had an allergic reaction to the flu vaccine. Reporter thought the allergy may be due to the egg component even though patient can eat eggs on a daily basis. Brand of flu vaccine was unknown. Reporter stated that vaccine was administered several years ago at a different facility, and that she had very limited details and declined to answer questions
Age: 0.17
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 9 week old patient of an unknown gender. On 15-JAN-2015, the patient was vaccinated with improperly stored ROTATEQ (lot # K007247 and expiry date 17-MAR-2016 or lot # K006805 and expiry date: 24-MAR-2016. No adverse events were reported. No product quality complaint (PQC) was reported for ROTATEQ. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 0.15
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 8 week old patient of an unknown gender. On 29-JAN-2015, the patient was vaccinated with improperly stored ROTATEQ (either lot # K007247 and expiry date: 17-MAR-2016 or lot # K006805 and expiry date: 24-MAR-2016. No adverse events were reported. No product quality complaint PQC was reported for ROTATEQ. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 14.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 14 year old patient of unknown gender. On 30-JAN-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 17.0
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a 17 year old patient of an unknown gender. On 16-FEB-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several; reports from the same reporter.  Additional information has been requested.